Biotechnology Stocks II Performance Guide: Arcturus Therapeutics Holdings Inc. (ARCT)
ARCT has no dividends.
Table and Chart of ARCT Performance
See what a $1,000 investment in ARCT is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| ARCT Returns | |
|---|---|
| Start Date | Jul-31-2014 |
| Start Price | $121.94 |
| End Date | Jul-26-2024 |
| End Price | $24.07 |
| # Prices | 121 |
| Min Date | Dec-31-2018 |
| Min Price | $4.53 |
| Max Date | Aug-29-2014 |
| Max Price | $134.82 |
| Total Return | -80.26% |
| Annualized Return | -14.86% |
| Current Value of $1,000 Purchase | $197 |
| Number Returns | 7,260 |
| Average Return | 81.05% |
| Number Profitable Returns | 3,636 |
| Percent Profitable Returns | 50.08% |
| Number Unprofitable Returns | 3,624 |
| Percent Unprofitable Returns | 49.92% |
| Profitable to Unprofitable Returns Ratio | 1.00 |
| ARCT Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $618,893,000 |
| Beta | 2.641 | Price to Sales | 4.91 |
| Earnings per Share | $-4.1400 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 2.946 |
| PRICE DATA | |
| 52 Week High | $45 |
| 52 Week Low | $17.52 |
| Analyst Target Price | $77.43 |
| 50-Day Moving Average | $28.79 |
| 200-Day Moving Average | $29.3 |
| FINANCIAL DATA | |
| Revenue per Share | $4.662 |
| Revenue | $124,526,000 |
| Profit Margin | -86.2% |
| Return on Equity | -36.2% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
ARCT Compare Returns with S&P 500
ARCT Trendline Chart
ARCT Moving Average Chart
ARCT Stock Return Map - See Patterns of Gains and Losses
ARCT Stock Returns/Purchase Dates